Prenatal screening in the blood serum in the1st trimester of pregnancy (dual test for pregnancy-associated placental protein (PAPP-A) and β-unit chorionic gonadotropin (β-HCG) (expanded: Down syndrome, Patau/Edwards syndrome, Shershevsky-Turner syndrome)
Free certain hormones: pregnancy-associated plasma protein-A, β-HCG free in the first trimester (10 weeks - 13 weeks 6 days) SsdwLab 6.0.14 is based on a huge statistical database of scientific studies.
For a long time, scientists have examined pregnant women in many countries and have concluded that there is a bond between the ratio of different biological characteristics of a patient and the likelihood of having a child with genetic diseases. A powerful calculation algorithm including individual characteristics of mother and fetus provides an accurate risk assessment.
It takes into account:
- Gestational age;
- Ultrasound findings (fetus size, gestational age, MSD, NT scan);
- Race; Age;
- Social habits;
- Medication intake. Biochemical tests (10 weeks - 13 weeks 6 days): pregnancy-associated plasma protein-A, β-HCG free;
Special attention is paid to the ultrasound, as the reliability of the results depends on it to a greater extent. An example of a result: 1:80 is a high risk of pathology and means that only one woman out of 80 with similar tests and risk factors can give birth to a child with a genetic disease.
For the determination of biochemical markers OLYMP CDL uses modern high-precision platforms Cobas E8000 by Roche company. This company is one of only three FMF (International Fetal Medicine Foundation, UK) certified and accredited to perform prenatal screening tests. Roche's certified program - SsdwLab 6.0.14 - is used for computer processing and data retrieval to calculate first-trimester risks from week 10 to week 13 + 6 days based on ultrasound data and biochemical markers.
ATTENTION: Referral for examination is issued by the attending doctor on a special form, which can be obtained from the medical representative of СDL OLYMP in your region.